Large scale implementation of clinical medication reviews in Dutch community pharmacies: Drug-related problems and interventions

International Journal of Clinical Pharmacy

Volumn 36, Issue 3, 2014, Pages 630-635

  Kempen, Thomas G H ^a   Van De Steeg Van Gompel, Caroline H P A ^b   Hoogland, Petra ^c   Liu, Yuqian ^d   Bouvy, Marcel L ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b SIR Institute for Pharmacy Practice and Policy   (Netherlands)

^c Nederlandse Service Apotheek Beheer BV   (Netherlands)

^d UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Clinical medication review; Drug related problems; Pharmaceutical care; Pharmacist; Pharmacy practice; The Netherlands

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; LOOP DIURETIC AGENT; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; RETINOL; VITAMIN D;

ADVERSE DRUG REACTION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIABETES MELLITUS; HUMAN; NETHERLANDS; OSTEOPOROSIS; PHARMACY; PRIORITY JOURNAL; SIDE EFFECT; MEDICATION THERAPY MANAGEMENT; ORGANIZATION AND MANAGEMENT; RETROSPECTIVE STUDY;

COMMUNITY PHARMACY SERVICES; HUMANS; MEDICATION THERAPY MANAGEMENT; NETHERLANDS; RETROSPECTIVE STUDIES;

EID: 84901370035     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-014-9947-4     Document Type: Article

References (23)

1. FIP Working Group on Collaborative Practice. FIP reference paper collaborative practice. Den Haag: International Pharmaceutical Federation; 2009. http://www.fip.org/www/uploads/database-file.php?id=319&table-id=; accessed at: 9-12-2013.
2. Expertgroep Medicatieveiligheid [Expert Group Medication Safety]. HARM-WRESTLING. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport [Ministry of Health, Welfare and Sport]; 2009. http://www.knmp.nl/downloads/ medicijnen-zorgverlening/medicatieveiligheid/harmwrestlingrapportdefnov2009.pdf. Accessed at: 9 dec 2013.
3. Patterson S, Hughes C, Kerse N, Cardwell C, Bradley M. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:CD008165.
4. Task Force on Medicines Partnership and The National Collaborative Medicines Management Services Programme. Room for review. A guide to medication review: the agenda for patients, practitioners and managers. 1st ed. London: Medicines Partnership; 2002. ISBN 0-9544028-0-4.
5. Sorensen L, Stokes J, Purdie D, Woodward M, Elliott R, Roberts M. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648-64. (Pubitemid 39665152)
6. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323(7325):1340-3. (Pubitemid 33152213)
7. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ. 2005;330(7486):293.
8. Geurts MME, Talsma J, Brouwers JRBJ, de Gier J. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012;74(1):16-33.
9. Fiß T, Meinke-Franze C, van den Berg N, Hoffmann W. Effects of a three party healthcare network on the incidence levels of drug related problems. Int J Clin Pharm. 2013;35(5):763-71.
10. Milos V, Rekman E, Bondesson Å, Eriksson T, Jakobsson U, Westerlund T, et al. Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging. 2013;30(4):235-46.
11. Nederlands Huisartsen Genootschap ism andere beroepsorganisaties/ instanties/verenigingen [Dutch College of General Practitioners in collaboration with other professional organisations]. Multidisciplinaire Richtlijn Polyfarmacie bij ouderen, 2012 [Multidisciplinary Guideline Polypharmacy in Elderly]. NHG 2012. https://www.nhg.org/sites/default/files/content/nhg-org/ uploads/polyfarmacie-bij-ouderen.pdf; accessed at: 9-12-2013.
12. Denneboom W, Dautzenberg MGH, Grol R, De Smet PAGM. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract. 2007;57(542):723-31. (Pubitemid 47423018)
13. Leikola SNS, Virolainen J, Tuomainen L, Tuominen R, Airaksinen MSA. Comprehensive medication reviews for elderly patients: findings and recommendations to physicians. J Am Pharm Assoc. 2012;52(5):630-3.
14. Vinks THAM, Egberts TCG, de Lange T, de Koning FHP. Pharmacist-based medication review reduces potential drug-related problems in the elderly: the SMOG controlled trial. Drugs Aging. 2009;26(2):123-33.
15. Brulhart M, Wermeille J. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33(3):549-57.
16. Stafford A, Tenni P, Peterson G, Jackson S, Hejlesen A, Villesen C, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216-23.
17. Shimp L, Kucukarslan S, Elder J, Remington T, Wells T, Choe H, et al. Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs. J Am Pharm Assoc. 2012;52(6):768-76.
18. Nishtala P, McLachlan A, Bell JS, Chen T. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract. 2011;17(1):97-103.
19. Freeman C, Cottrell WN, Kyle G, Williams I, Nissen L. An evaluation of medication review reports across different settings. Int J Clin Pharm. 2013;35(1):5-13.
20. Kwint HF, Faber A, Gussekloo J, Bouvy ML. The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther. 2012;37(6):674-80.
21. Stichting Farmaceutische Kengetallen [Foundation for Pharmaceutical Statistics]. Data en feiten 2013 [Data and facts 2013]. Den Haag: SFK; 2012. ISBN 978-90-817780-1-5.
22. Gezondheidsraad [Health Council of the Netherlands]. Evaluatie van de voedingsnormen voor vitamine D [Evaluation of the dietary reference values for vitamin D]. Den Haag: Gezondheidsraad; 2012. 150 p. Report No.: 2012/15. ISBN 978-90-5549-931-1.
23. Lau HS, de Boer A, Beuning KS, Porsius A. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50(5):619-25. (Pubitemid 27270212)